FADD was deficient in certain types of cancer, such as thymic lymphoma, acute myeloid leukemia (AML), and glioblastoma (GBM) (Newton et al. 2000; Tourneur et al. 2004; Wang et al. 2017). The gene discussed is FADD; the disease is acute myeloid leukemia.